Wolverine Trading
CPRX

Wolverine Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Wolverine Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,700
Closed -$282K – 4584
2024
Q1 		$282K Buy
+17,700
New +$267K ﹤0.01% 3425
2023
Q4 		– Sell
-16,300
Closed -$191K – 4580
2023
Q3 		$191K Buy
16,300
+5,400
+50% +$72.2K ﹤0.01% 3767
2023
Q2 		$147K Sell
10,900
-18,600
-63% -$268K ﹤0.01% 3639
2023
Q1 		$486K Sell
29,500
-7,300
-20% -$120K ﹤0.01% 2531
2022
Q4 		$684K Buy
36,800
+21,900
+147% +$337K ﹤0.01% 2121
2022
Q3 		$189K Sell
14,900
-1,900
-11% -$22.5K ﹤0.01% 3648
2022
Q2 		$117K Buy
+16,800
New +$123K ﹤0.01% 3776
2021
Q2 		– Sell
-25,400
Closed -$110K – 6106
2021
Q1 		$110K Buy
25,400
+13,300
+110% +$52.8K ﹤0.01% 5398
2020
Q4 		$41K Sell
12,100
-2,100
-15% -$7.05K ﹤0.01% 4638
2020
Q3 		$46K Buy
+14,200
New +$55.5K ﹤0.01% 4287
2020
Q2 		– Sell
-24,800
Closed -$96K – 4651
2020
Q1 		$96K Buy
24,800
+5,700
+30% +$23.4K ﹤0.01% 4033
2019
Q4 		$70K Buy
+19,100
New +$89.3K ﹤0.01% 4377
2019
Q3 		– Sell
-30,500
Closed -$117K – 4411
2019
Q2 		$117K Buy
+30,500
New +$132K ﹤0.01% 3958
2018
Q4 		– Sell
-12,200
Closed -$46K – 4542
2018
Q3 		$46K Buy
+12,200
New +$38.2K ﹤0.01% 4715
2018
Q1 		– Sell
-15,100
Closed -$59K – 5177
2017
Q4 		$59K Buy
+15,100
New +$49.9K ﹤0.01% 4577
2017
Q2 		– Sell
-19,000
Closed -$38K – 4339
2017
Q1 		$38K Buy
+19,000
New +$24.2K ﹤0.01% 4039

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wolverine Trading's CPRX Position: Q3 2024 in Review

Wolverine Trading sold out of Catalyst Pharmaceutical (CPRX) in Q3 2024, closing a stake of 10,609 shares — an estimated $164K sold.

Wolverine Trading first reported a position in CPRX in Q3 2018 and held it in 7 quarters. The position peaked at $391K in Q4 2022. 316 funds tracked by Wall St. Rank hold CPRX as of Q3 2024.

  • Wolverine Trading reported no remaining Catalyst Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 10,609 Catalyst Pharmaceutical shares in Q3 2024, an estimated $164K.
  • Wolverine Trading first reported a position in Catalyst Pharmaceutical in Q3 2018 and held it in 7 quarters.
  • Wolverine Trading's Catalyst Pharmaceutical position peaked at $391K in Q4 2022.
  • 316 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.